Skip to main content

Home/ Cancer/ Group items tagged Pan

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesi... - 0 views

cancerres.aacrjournals.org/...4854

Copper Deficiency Tetrathiomolybdate Suppresses Tumor cancer Growth Angiogenesis anti-copper anti-angiogenesis anti-angiogenic agent inhibition inhibitor inhibitors medicine medline oncology science study research peer-reviewed treatment therapy imported

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Q. Pan, C. G. Kleer, K. L. van Golen, J. Irani, K. M. Bottema, C. Bias, M. De Carvalho, E. A. Mesri, D. M. Robins, R. D. Dick, G. J. Brewer, and S. D. Merajver Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis Canc
Matti Narkia

Antiangiogenic Tetrathiomolybdate Enhances the Efficacy of Doxorubicin against Breast C... - 0 views

mct.aacrjournals.org/...617

anti-angiogenic anti-angiogenesis anti-copper angiogenesis Tetrathiomolybdate Doxorubicin Breast Carcinoma cancer chemotherapy agent inhibition inhibitor inhibitors copper reduction science study research medicine medline peer-reviewed impor breast_cancer

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Mol Cancer Ther. 2003 Jul;2(7):617-22. PMID: 12883034 [PubMed - indexed for MEDLINE]
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman ... - 0 views

clincancerres.aacrjournals.org/...1666

Phase-II phaseII Trial Tetrathiomolybdate Advanced Kidney Cancer renal kidneycancer clinicaltrial anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis copper inhibition inhibitor inhibitors reduction medicine medline oncology science study res

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressi... - 0 views

mct.aacrjournals.org/...1039

Hassouneh B Islam M Nagel T Pan Q Merajver SD Teknos TN. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head neck cancer. Mol Cancer Ther. 2007 Mar;6(3):1039-45. PMID: 17363496 [PubMed inhibi

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer -- Hassouneh et al. 6 (3): 1039 -- Molecular Cancer Therapeutics
1 - 4 of 4
Showing 20▼ items per page